ABT was off 1.6% today on the AIM-HIGH news, which is clearly bearish for Niaspan sales. Niaspan comprises 2.6% of ABT’s overall sales and probably 3-4% of its profits.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”